fda bpc-157 unapproved peptide warning Everything You Need to Know About the Ban On Peptides, FDA Staff Scientists

A recent analysis of the USFDA Adverse Event Reporting System revealed that patients taking both metformin and a PPI experienced significantly higher rates of hospitalizations and life-threatening complications related to B12 deficiency (such as severe neuropathy and cognitive decline) compared to those on monotherapy

99.9% Oral Bioavailable Backed by 200+ studies, showing promise across gut health, joint repair, and inflammation

503A pharmacy source matters: The before and after results we see at our clinic come from pharmaceutical-grade 503A compounded BPC-157

*By completing this form, you are signing up to receive our marketing emails and will receive a confirmation email